These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7736385)

  • 21. Postoperative recurrence of hepatocellular carcinoma: results of transcatheter arterial chemoembolization.
    Park JH; Han JK; Chung JW; Han MC; Kim ST
    Cardiovasc Intervent Radiol; 1993; 16(1):21-4. PubMed ID: 8382109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil.
    Beppu T; Ohara C; Yamaguchi Y; Ichihara T; Yamanaka T; Katafuchi S; Ikei S; Mori K; Fukushima S; Nakano M
    Cancer; 1991 Dec; 68(12):2555-60. PubMed ID: 1657361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of RECIST and mRECIST criteria as prognostic factors in patients undergoing repeated iodized oil chemoembolization of intermediate stage hepatocellular carcinoma.
    Hyun D; Shin SW; Cho SK; Park KB; Park HS; Choo SW; Do YS; Choo IW; Shin JW; Lim SJ
    Acta Radiol; 2015 Dec; 56(12):1437-45. PubMed ID: 25480473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.
    Seong J; Keum KC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):393-7. PubMed ID: 10030267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
    Hashimoto N; Kawai S; Mikuriya S; Oda T; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Yumoto Y; Makino M
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S21-5. PubMed ID: 2466582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma.
    Jaeger HJ; Mehring UM; Castañeda F; Hasse F; Blumhardt G; Loehlein D; Mathias KD
    Cardiovasc Intervent Radiol; 1996; 19(6):388-96. PubMed ID: 8994703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
    Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
    Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
    Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.
    Ko HK; Ko GY; Yoon HK; Sung KB
    Korean J Radiol; 2007; 8(4):320-7. PubMed ID: 17673843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
    Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.